John Drayton Wise - 25 May 2023 Form 4 Insider Report for INSMED Inc (INSM)

Reporting relationship: Chief Commercial Officer
Issuer ticker: INSM
Reported as of: 25 May 2023
Net transaction value: -$63,786
SEC form: 4
Accepted by SEC: 26 May 2023, 16:05:43 UTC
Prior SEC filing: 17 May 2023
Next SEC filing: 05 Jan 2024
Source filing: View source filing
Reporting owner signature: /s/ John Drayton Wise, by Michael A. Smith as Attorney-in-fact

Key filing fact

John Drayton Wise filed Form 4 for INSMED Inc (INSM) on 26 May 2023.

Key facts

This page summarizes John Drayton Wise's Form 4 filing for INSMED Inc (INSM).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 26 May 2023, 16:05.

Change

Previous filing in this sequence was filed on 17 May 2023.
Current net transaction value: -$63,786.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

INSM transaction

Common Stock

Sale

Transaction value: $63,786
Shares: -3,366
Change %: -3.2%
Price: $18.95
Shares after: 102,681
Date: 25 May 2023
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees.

Footnote F2

This is the weighted average sales price representing 3,366 shares sold at prices ranging from $18.93 to $18.95 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.